v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT05279430 |
|
Full text link
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : Dec. 15, 2022, noon Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : Dec. 15, 2022, noon Source : ClinicalTrials.gov |
Not reported |
|
Registration date
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
2022-03-15 |
|
Recruitment status
Last imported at : Dec. 15, 2022, noon Source : ClinicalTrials.gov |
Completed |
|
Study design
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
Blind label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
Long covid |
|
Inclusion criteria
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
inclusion criteria: symptomatic adult patients >18 years old with the previous admission due to sars-cov-2 pneumonia > 3-month after discharge the patient provides informed consent |
|
Exclusion criteria
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
inability to perform a maximal baseline exercise test structural heart disease, valve heart disease, or diastolic dysfunction estimated by 2-dimensional echocardiography patients with previous ischemic heart disease, heart failure, myocardiopathy, or myocarditis effort angina or signs of ischemia during cpet significant primary pulmonary disease, including a history of pulmonary arterial hypertension, chronic thromboembolic pulmonary disease, or chronic obstructive pulmonary disease (g) treatment with digitalis, calcium channel blockers, β-blocker or ivabradine (h) patients with chronic kidney disease (glomerular filtration rate <60ml/min/1.73m2) (i) patients with pacemakers or previous history of atrial fibrillation; (j) patients with autoimmune, inflammatory or active neoplastic disease k) anemia (l) pregnancy. |
|
Number of arms
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
2 |
|
Funding
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
Fundación para la Investigación del Hospital Clínico de Valencia |
|
Inclusion age min
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
18 |
|
Inclusion age max
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
90 |
|
Countries
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
Spain |
|
Type of patients
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
|
Severity scale
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
N/A |
|
Total sample size
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
26 |
|
primary outcome
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
Peak oxygen consumption |
|
Notes
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : March 18, 2022, 1 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "nan", "treatment_id": 657, "treatment_name": "Inspiratory muscle training", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |